Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Protara Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.50 | -$0.45 | -$0.48 |
| Q2 2025 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q3 2025 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q4 2025 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q1 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q2 2026 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q3 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2026 | 1 | -$0.54 | -$0.54 | -$0.54 |
Protara Therapeutics, Inc. Earnings Date And Information
Protara Therapeutics, Inc. last posted its earnings results on Wednesday, March 5th, 2025. The company reported $-0.48 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Protara Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-2.17 diluted earnings per share) and currently has a price-to-earnings ratio of -1.88. Protara Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based on prior year's report dates.
Protara Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/05/2025 | Q4 2024 | -$0.57 | -$0.59 | -0.02 | $0 | $0 |
| 11/12/2024 | Q3 2024 | -$0.50 | -$0.50 | 0 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.82 | -$0.45 | 0.37 | $0 | $0 |
| 05/02/2024 | Q1 2024 | -$0.99 | -$0.97 | 0.02 | N/A | $0 |
| 03/13/2024 | Q4 2023 | -$1.03 | -$0.90 | 0.13 | N/A | $1.21 M |
| 11/03/2023 | Q3 2023 | -$1.10 | -$0.87 | 0.23 | N/A | $0 |
| 08/03/2023 | Q2 2023 | -$0.97 | -$1.00 | -0.03 | N/A | $0 |
| 05/04/2023 | Q1 2023 | -$1.00 | -$0.74 | 0.26 | N/A | $0 |
| 03/08/2023 | Q4 2022 | -$0.77 | -$3.45 | -2.68 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$0.85 | -$0.66 | 0.19 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$1.13 | -$0.73 | 0.4 | N/A | $0 |
| 05/05/2022 | Q1 2022 | -$1.09 | -$0.95 | 0.14 | N/A | $0 |
| 03/09/2022 | Q4 2021 | -$0.94 | -$0.91 | 0.03 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$1.15 | -$0.96 | 0.19 | N/A | $0 |
| 08/05/2021 | Q2 2021 | -$1.14 | -$1.14 | 0 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$0.92 | -$1.20 | -0.28 | N/A | $0 |
| 03/11/2021 | Q4 2020 | -$0.42 | -$0.79 | -0.37 | N/A | $0 |
| 11/12/2020 | Q3 2020 | -$0.62 | -$1.26 | -0.64 | N/A | $0 |
| 07/31/2020 | Q2 2020 | -$0.46 | -$1.22 | -0.76 | N/A | $0 |
| 05/12/2020 | Q1 2020 | -$0.41 | -$1.81 | -1.4 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protara Therapeutics, Inc. Earnings: FAQ's
Protara Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based offlast year's report dates.
In the previous quarter, Protara Therapeutics, Inc. (:TARA) reported $-0.48 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.09.
The conference call for Protara Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Protara Therapeutics, Inc.'s latest earnings report can be read online.
Protara Therapeutics, Inc. (:TARA) has a recorded net income of $-44,596,000.Protara Therapeutics, Inc. has generated $-2.17 earnings per share over the last four quarters.
Protara Therapeutics, Inc. (:TARA) has a price-to-earnings ratio of -1.88 and price/earnings-to-growth ratio is -0.17.